Briefing is the second in a three-part series on "Achieving Recovery Through Discovery"
WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics. The Council believes a robust infrastructure for translational research that transforms clinical research into practical treatments quickly and efficiently is critical to ensuring new, life-saving medical treatments reach the market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )
This is the second in a three-part briefing series examining the role of public policy in promoting medical innovation to help our nation recover from health and economic crises. For details on other briefings, visit: www.americanmedicalinnovation.org.
WHO: Remarks by:
*Debra Lappin and other panelists will be available for media interviews between 10:00 and 10:30 a.m. Please contact Laura Lowery, 206-799-5604 to secure an interview.
WHERE: Rayburn House Office Building, Room B338
WHEN: Thursday, September 17, 2009
8:30 - 10:00 a.m.
About the Council for American Medical Innovation
The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America's economic recovery, future prosperity and health.
For more information on the Council for American Medical Innovation, visit www.americanmedicalinnovation.org.
-- Amy Comstock Rick, CEO of the Parkinson's Action Network -- The Honorable Patrick Kennedy, U.S. Representative (D-RI) (invited) -- Debra Lappin, President of the Council for American Medical Innovation -- Alan Leshner, Ph.D., President of the American Association for the Advancement of Science (AAAS) -- Lesa Mitchell, Vice President of the Ewing Marion Kauffman Foundation
SOURCE Council for American Medical Innovation